Editas Medicine announced that it intends to offer and sell $125M of shares of its common stock in an underwritten public offering. J.P. Morgan Securities, Cowen and Company, and Evercore Group are acting as joint book-running managers for the offering.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on EDIT:
- Editas Medicine Announces Pricing of Offering of Common Stock
- Planned Stock Offering Puts EDIT Stock in a Tailspin
- Editas Medicine Announces Offering of Common Stock
- Editas upgraded to Outperform at Raymond James after early EDIT-301 data
- Editas Medicine upgraded to Outperform from Market Perform at Raymond James